Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05943626

Circadian Intervention to Improve Cardiometabolic Health

The overall goal is to examine the efficacy of a circadian intervention in people with overweight and obesity and habitual short sleep duration (HSSD). Participants will undergo a randomized controlled trial, with circadian intervention and control (healthy lifestyle) groups. The circadian intervention is designed to reduce nighttime light exposure and after-dinner snack food intake. Alternatively, the control group will receive basic health information (e.g., physical activity, goal setting, and nutrition when eating out).

Recruiting

Interested in participating?

Request Info

Key information

About this study

The study is a randomized controlled trial with control and circadian intervention groups. Group allocation will be blinded to research staff and participants until the conclusion of the baseline segment. The circadian intervention group will receive counseling and instruction to reduce evening and nighttime light exposure, increase morning room light and sunlight exposure, and complete all food consumption at least 4 hours before bedtime. Participants randomized to control will maintain their habitual food intake and sleep habits in their home environment for ~8 weeks. Both groups will have equal contact time with the study team.

Prior to enrollment participants will complete an clinical overnight sleep disorders screening. Baseline consists of an ~1-week ambulatory real-world monitoring segment. Following baseline participants will be randomized to the control or intervention groups for the 8 week experimental segment. Throughout the study sleep duration will be monitored using an actiwatch wrist-device and a daily electronic sleep log. At the end of the baseline and experimental segments participants will complete overnight laboratory visits to assess insulin sensitivity and circadian timing by oral glucose tolerance test and dim light melatonin onset, respectively.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age: 18-45 years old; equal numbers of men and women
  • Body mass index (BMI): 25.0-34.9 kg/m2,
  • Sleep Habits: habitual self-reported average total sleep time (TST) <6.5 hours per night for prior 6 months

Exclusion criteria

  • Clinically diagnosed sleep disorder or major psychiatric illness
  • Evidence of significant organ dysfunction or disease (e.g., diagnosed diabetes, cardiovascular disease, or kidney disease)
  • Use of prescription drugs or substances known to influence sleep or glucose metabolism
  • Shift-work: current or history of within last year
  • Weight change: >10% of body weight over prior six months
  • Experiencing menopause or post-menopausal
  • Current enrollment in weight loss or physical activity program like the Diabetes Prevention Program
  • Currently pregnant or planning to become pregnant, or currently lactating.
  • Currently smoking
  • Alcohol intake >3 drinks per day or >14 drinks per week

Treatment and study plan

Circadian Intervention

Behavioral

The circadian intervention group will receive counseling and instruction to reduce evening and nighttime light exposure, increase morning room light and sunlight exposure, and to finish all food consumption at least 4 hours before bedtime.

Primary outcomes

  1. Insulin sensitivity change from baseline

    Time frame: Change from baseline to end of the ~8 week experimental segment

    Oral Glucose Tolerance Test (OGTT), Matsuda Index

Secondary outcomes

  1. Timing of central circadian clock change from baseline

    Time frame: Change from baseline to end of the ~8 week experimental segment

    Quantified as dim-light melatonin onset from salivary melatonin samples

  2. Plasma ceramides change from baseline

    Time frame: Change from baseline to end of the ~8 week experimental segment

    Fasting plasma samples will be analyzed for plasma ceramides using targeted metabolomics

  3. Average (per week) nightly total sleep time change from baseline

    Time frame: Analyzed as change from baseline for each week of the ~8 week experimental segment

    Analyzed by wrist-actigraphy

  4. Average (per week) sleep satisfaction change from baseline

    Time frame: Analyzed as change from baseline for each week of the ~8 week experimental segment

    5 point likert scale on daily sleep log (1 = very good; 5 = very poor)

  5. Average (per week) self-reported sleep duration change from baseline

    Time frame: Analyzed as change from baseline for each week of the ~8 week experimental segment

    Daily electronic sleep logs will be used to track sleep and waketimes during the ambulatory monitoring phases of the study

  6. Average (per week) timing of food intake change from baseline

    Time frame: Change from baseline to week 8 of the ~8 week experimental segment

    Time of day 50% of calories are consumed collected by picture based food diaries. Average per week will consist of 2 weekdays and 1 weekend day for baseline and final week of intervention

  7. Average (per week) daytime alertness change from baseline

    Time frame: Analyzed as change from baseline for each week of the ~8 week experimental segment

    5 point likert scale on daily sleep log (1= most alert; 5 = not alert at all)

Study contacts

Contact information is provided by the study sponsor or research team.

Christopher M Depner, PhD

CONTACT

[email protected]

801-581-2275

Sponsors and collaborators

Lead sponsor

University of Utah

Other

Registry information

Official study title

Timing of Circadian Synchronizers: the TOCS Study

Acronym: TOCS

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Jul 13, 2023
Registry last updated
Dec 20, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.